Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 71-76

  Nielsen, Stine E ^a   Reinhard, Henrik ^a   Zdunek, Dietmar ^b   Hess, Georg ^c   Gutiérrez, Orlando M ^d   Wolf, Myles ^e   Parving, Hans Henrik ^f,g   Jacobsen, Peter K ^f   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f Rigshospitalet   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

Author keywords

Diabetic nephropathy; FGF23; Tubules; Type 2 diabetes

Indexed keywords

ALBUMIN; FIBROBLAST GROWTH FACTOR 23; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; DETERIORATION; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROTEINURIA;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY TUBULES; MALE; MIDDLE AGED; PROTEINURIA;

EID: 84864109785     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.02.007     Document Type: Article

References (22)

1. Parving H.-H., Mauer M., Ritz E. Diabetic nephropathy. Brenner & Rector's THE KIDNEY 2008, 1265-1298. WB Saunders, Boston, USA. 8th ed. B.M. Brenner (Ed.).
2. Gilbert R.E., Cooper M.E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?. Kidney Int 1999, 56(5):1627-1637.
3. Cowland J.B., Sorensen O.E., Sehested M., Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003, 171(12):6630-6639.
4. Mori K., Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007, 71(10):967-970.
5. Vaidya V.S., Ramirez V., Ichimura T., Bobadilla N.A., Bonventre J.V. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006, 290(2):F517-F529.
6. van Timmeren M.M., van den Heuvel M.C., Bailly V., Bakker S.J., van G.H., Stegeman C.A. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007, 212(2):209-217.
7. Nielsen S.E., Schjoedt K.J., Astrup A.S., Tarnow L., Lajer M., Hansen P.R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 2010, 27(10):1144-1150.
8. Nielsen S.E., Andersen S., Zdunek D., Hess G., Parving H.H., Rossing P. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 2011, 79(10):1113-1118.
9. Parker B.D., Schurgers L.J., Brandenburg V.M., Christenson R.H., Vermeer C., Ketteler M., et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 2010, 152(10):640-648.
10. Mirza M.A., Larsson A., Lind L., Larsson T.E. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009, 205(2):385-390.
11. Fliser D., Kollerits B., Neyer U., Ankerst D.P., Lhotta K., Lingenhel A., et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 2007, 18(9):2600-2608.
12. Titan S.M., Zatz R., Graciolli F.G., dos Reis L.M., Barros R.T., Jorgetti V., et al. FGF-23 as a predictor of renal outcome in diabetic nephropathy. Clin J Am Soc Nephrol 2011, 6(2):241-247.
13. Reinhard H., Hansen P.R., Persson F., Tarnow L., Wiinberg N., Kjaer A., et al. Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant 2011, 26(10):3242-3249.
14. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation, 2006. Geneva, World Health Organization. Ref Type: Generic.
15. Bader R., Bader H., Grund K.E., Mackensen-Haen S., Christ H., Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: correlations between morphological and functional parameters. Pathol Res Pract 1980, 167:204-216.
16. Bolignano D., Donato V., Coppolino G., Campo S., Buemi A., Lacquaniti A., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008, 52(3):595-605.
17. Bolignano D., Lacquaniti A., Coppolino G., Donato V., Fazio M.R., Nicocia G., et al. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 2009, 32(2):91-98.
18. Bolignano D., Lacquaniti A., Coppolino G., Donato V., Campo S., Fazio M.R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009, 4(2):337-344.
19. Vaidya V.S., Niewczas M.A., Ficociello L.H., Johnson A.C., Collings F.B., Warram J.H., et al. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-beta-d-glucosaminidase. Kidney Int 2011, 79(4):464-470.
20. Fioretto P., Mauer S.M., Brocco E., Velussi M., Frigato F., Muollo B., et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 1996, 39:1569-1576.
21. Isakova T., Xie H., Yang W., Xie D., Anderson A.H., Scialla J., et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011, 305(23):2432-2439.
22. Rossing P., Rossing K., Gaede P., Pedersen O., Parving H.-H. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care 2006, 29(5):1024-1030.